Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA
This article was originally published in The Tan Sheet
Executive Summary
A potential "reverse switch" of pediatric cough/cold OTC drugs to prescription status would not address concerns about efficacy or misuse of the products, the Consumer Healthcare Products Association says
You may also be interested in...
Bionorica Steers U.S. Consumers To Natural Products Through Science
Natural product marketer Bionorica looks to science to convince parents about the efficacy of natural remedies for children while they become more aware of possible risks associated with OTC cough and cold formulas
Bionorica Steers U.S. Consumers To Natural Products Through Science
Natural product marketer Bionorica looks to science to convince parents about the efficacy of natural remedies for children while they become more aware of possible risks associated with OTC cough and cold formulas
Bionorica Steers U.S. Consumers To Natural Products Through Science
Natural product marketer Bionorica looks to science to convince parents about the efficacy of natural remedies for children while they become more aware of possible risks associated with OTC cough and cold formulas